SEC Form 4 · accession 0001144204-15-040946
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew L Pecora
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 30, 2015 | A | 6,702 | $1.5895 | A | 364,658 | D | |
| Common Stock, $0.001 par value | Jun 30, 2015 | A | 227 | $1.87 | A | 364,885 | D | |
| Common Stock, $0.001 par value | Jul 2, 2015 | A | 2,097 | $1.89 | A | 366,982 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares purchased pursuant to Caladrius Biosciences, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2015.
- F2Effective August 15, 2013, the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive a portion of his net salary through the issuance to him by the Issuer of shares of the Issuer's common stock, $.001 par value (the "Common Stock") at the then-market price at the time of issuance, under and subject to the terms and conditions of the Issuers' Amended & Restated 2009 Equity Compensation Plan (the "Plan").